Segment Information

9 Months Ended

Sep. 30, 2015

Segment Information

Segment Information

Note 13Segment Information

AbbVie operates in one business segment—pharmaceutical products. Substantially all of AbbVie’s net revenues in the United States are to three wholesalers. Outside the United States, products are sold primarily to health care providers or through distributors, depending on the market served. The following table details AbbVie’s worldwide net revenues:

	Three months ended September 30,		Nine months ended September 30,
(in millions)	2015	2014	2015	2014
HUMIRA	$ 3,647	$ 3,255	$ 10,295	$ 9,180
IMBRUVICA	304	—	411	—
VIEKIRA	469	—	1,085	—
Creon	161	148	447	365
Synagis	93	109	474	537
Lupron	201	196	591	571
Synthroid	188	200	561	523
Kaletra	168	256	515	667
AndroGel	177	232	500	704
Sevoflurane	122	134	366	430
Duodopa	61	56	169	164
Dyslipidemia products	43	63	124	224
All other	310	370	921	1,143
Total net revenues	$ 5,944	$ 5,019	$ 16,459	$ 14,508